PBMs

Patient groups sue feds to crack down on insurer, PBM copay adjustment programs
Fierce Healthcare
Wed, 08/31/22 - 10:37 am
PBMs
copay asssistance programs
drug pricing
HHS
FTC Unanimously Agrees to Keep Close Eye on PBMs, Higher Drug Costs
BioSpace
Mon, 06/20/22 - 10:27 am
FTC
PBMs
drug pricing
FTC targets insulin, threatening to go after PBM-pharma deals that steer into 'commercial bribery'
Endpoints
Fri, 06/17/22 - 10:04 am
FTC
insulin
diabetes
drug pricing
PBMs
FTC launches probe into pharmacy benefit management sector
Pharmaforum
Wed, 06/8/22 - 10:11 am
FTC
PBMs
drug pricing
Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill
Endpoints
Thu, 05/26/22 - 10:48 pm
FTC
PBMs
regulatory
Senate
Eli Lilly, Novo Nordisk and Sanofi face new lawsuit from Arkansas AG over insulin prices
Fierce Pharma
Thu, 05/12/22 - 10:54 pm
Eli Lilly
Novo Nordisk
Sanofi
Arkansas
insulin
drug pricing
PBMs
diabetes
PBMs in the Senate hot seat as bipartisan transparency measures may take root
Endpoints
Thu, 05/5/22 - 11:25 pm
PBMs
Senate
transparency
Community welcomes President Biden’s call to action to rein in high drug prices
MedCity News
Mon, 04/25/22 - 10:14 am
drug pricing
Joe Biden
PBMs
congress
40% of CVS Caremark's PBM clients have a negative specialty drug trend
Beckers Hospital Review
Fri, 02/25/22 - 10:17 am
CVS Caremark
PBMs
specialty drugs
When the $10K brand name drug is more affordable than its $450 generic: How PBMs control the system
Endpoints
Sun, 02/20/22 - 11:52 am
PBMs
drug pricing
generics
FTC deadlocks on vote to launch study into PBM practices
BioPharma Dive
Fri, 02/18/22 - 10:33 am
FTC
PBMs
drug pricing
FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies
Endpoints
Wed, 02/16/22 - 11:16 pm
FTC
PBMs
drug pricing
competition
PBMs ranked by market share: CVS Caremark is No. 1
Beckers Hospital Review
Wed, 02/9/22 - 10:02 am
PBMs
CVS Caremark
Express Scripts
OptumRx
Mark Cuban's new cost-plus-15% generic drug company is really a compounding pharmacy
Endpoints
Mon, 01/31/22 - 11:44 pm
Mark Cuban
Mark Cuban Cost Plus Drugs
PBMs
compounding pharmacies
3 forecasts for the PBM industry in 2022
MedCity News
Fri, 01/28/22 - 10:11 am
PBMs
Five Takeaways from the Big Three PBMs’ 2022 Formulary Exclusions
Drug Channels
Wed, 01/19/22 - 10:58 am
PBMs
formularies
CVS Health
Caremark
Express Scripts
OptumRx
insulin
PBMs' profits are increasing while their revenue sources remain unclear, report says
Beckers Hospital Review
Thu, 12/2/21 - 10:53 pm
PBMs
Mark Cuban's drug company to launch PBM
Beckers Hospital Review
Mon, 10/25/21 - 11:56 pm
Mark Cuban
PBMs
GoodRx strikes deal with medication data giant Surescripts
MedCity News
Thu, 08/5/21 - 10:45 am
GoodRx
Surescripts
PBMs
e-prescribing
Anthem, Humana join hedge fund to launch PBM
MedCity News
Wed, 07/28/21 - 10:23 am
PBMs
payers
Anthem
Humana
hedge funds
DomaniRx

Pages